Jasper Therapeutics, Inc. (JSPR) NASDAQ

1.83

+0.02(+1.10%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap311.83M
Enterprise Value242M
P/E Ratio-0.43
PEG Ratio0.03
Price/Sales Ratio25.33
Price/Book Ratio1.17
Enterprise/Revenue-6.48
Enterprise/EBITDA0.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-54.68
Operating Margin-80.11

Management Effectiveness

Return On Assets-1.38
Return On Equity-1.22

Income Statement

Revenue0
Revenue/Share0.08
Gross Profit0
EBITDA-74.87M
Net Income-71.27M
Diluted EPS-4.89

Balance Sheet

Total Cash50.9M
Total Cash/Share2.63
Total Debt1.7M
Total Debt/Equity0.09
Current Ratio2.1
Book Value Per Share1.56

Price History

52-Week Change-91.57
52-Week High22.99
52-Week Low1.39
Moving Average 50 Days1.95
Moving Average 200 Days3.48

Statistics

Average Volume1.57M
Shares Outstanding16.25M
% Held by Institutions134.17

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJanuary 04, 2024